Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00572013
Recruitment Status : Completed
First Posted : December 12, 2007
Last Update Posted : January 17, 2018
Information provided by (Responsible Party):
Julie M Vose, MD, University of Nebraska

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2001
  Study Completion Date : September 2009